Advertisement
Research Article| Volume 10, ISSUE 1, P59-76, March 1990

Immunohfstochemistry in Surgical Pathology: The Case of the Undifferentiated Malignant Neoplasm

  • James Linder
    Correspondence
    Address reprint requests to: James Linder, MD Department of Pathology and Microbiology, University of Nebraska Medical Center, 42nd and Dewey Avenues, Omaha, NE 68105
    Affiliations
    Professor of Pathology and Microbiology, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska.
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30582-1
Immunohfstochemistry in Surgical Pathology: The Case of the Undifferentiated Malignant Neoplasm
Previous ArticleTumor Markers in Endocrine Malignancies
Next ArticleThe Application of Monoclonal Antibodies in the Cytologic Evaluation of Tumors
      This paper is only available as a PDF. To read, Please Download here.
      This article outlines a multifaceted, practical approach for the identification of undifferentiated neoplasms. Issues relating to sensitivity and specificity are carefully considered. The approach to using commercial immunocytochemical kits is outlined.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Asumi N.
        • Ben-Ezra J.
        • Battifora H.
        Immunophenotypic diagnosis of leiomyosarcomas and rhabdomyosarcomas with monoclonal antibodies to muscle-specific actin and desmin in formalin-fixed tissue.
        Mod Pathol. 1988; 1: 469
        • Azumi N.
        • Battifora H.
        The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin-and alcohol-fixed tumors.
        Am J Clin Pathol. 1987; 88: 286
        • Baumal R.
        • Kahn H.J.
        • Bailey D.
        • et al.
        The value of immunohistochemistry in increasing diagnostic precision of undifferentiated tumours by the surgical pathologist.
        Hist-chemj. 1984; 16: 1061
        • Borowitz M.H.
        • Stevanovic G.
        • Gottfried M.
        Differential diagnosis of undifferentiated malignant tumors with monoclonal antibody T29/33.
        Hum Pathol. 1984; 15: 928
        • Cartun R.W.
        • Coles F.B.
        • Pastuszak W.T.
        Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
        Am J Pathol. 1987; 129: 415
        • Cheng L.
        • Binder S.W.
        • Fu Y.S.
        • et al.
        Methods in laboratory investigation. Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors.
        Lab Invest. 1988; 58: 346
        • Cooper D.
        • Schermer A.
        • Sun T.T.
        Biology of disease. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications, and limitations.
        Lab Invest. 1985; 52: 243
        • Drier J.K.
        • Swanson P.E.
        • Cherwitz D.L.
        • et al.
        S100 protein immunoreactivity in poorly differentiated carcinomas.
        Arch Pathol Lab Med. 1987; 111: 447
        • Epstein A.L.
        • Marder R.J.
        • Winter J.N.
        • et al.
        Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
        J Immunol. 1984; 133: 1028
        • Gabbiani G.
        • Kapanici Y.
        • Barazzone P.
        • et al.
        Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist.
        Am J Pathol. 1981; 104: 206
        • Gatter K.C.
        • Alcock C.
        • Heryet A.
        • et al.
        The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies.
        Am J Clin Pathol. 1984; 82: 33
        • Gatter K.C.
        • Heryet A.
        • Alcock C.
        • et al.
        Clinical importance of analyzing malignant tumours of uncertain origin with immunohistologic techniques.
        Lancet. 1985; 1: 1302
        • Gown A.M.
        • Boyd H.C.
        • Chang Y.
        • et al.
        Smooth muscle cells can express cytokeratins of “simple” epithelium. Immunocytochemical and biochemical studies in vitro and in vivo.
        Am J Pathol. 1988; 132: 223
        • Gown A.M.
        • Vogel A.M.
        • Hoak D.
        • et al.
        Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
        Am J Pathol. 1986; 123: 195
        • Gown A.M.
        • Vogel A.M.
        Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors.
        Am J Clin Pathol. 1985; 84: 413
        • Herrera G.A.
        • Turbat-Herrera E.A.
        • Lott R.L.
        S-100 protein expression by primary and metastatic adenocarcinomas.
        Am J Clin Pathol. 1988; 89: 168
        • Johnson D.E.
        • Herndier B.G.
        • Medeiros L.J.
        • et al.
        The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma.
        Am J Surg Pathol. 1988; 12: 187
        • Kahn H.J.
        • Thorner P.S.
        • Yeger H.
        • et al.
        Distinct keratin patterns demonstrated by immunoperoxidase staining of adenocarcinomas, carcinoids, and mesotheliomas using polyclonal and monoclonal anti-keratin antibodies.
        Am J Clin Pathol. 1986; 86: 566
        • Kurtin P.G.
        • Pinkus G.S.
        Leukocyte common antigen—A diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: Correlation with immunologic studies and ultrastructural localization.
        Hum Pathol. 1985; 16: 353
        • Lazarides E.
        Intermediate filaments as mechanical integrators of cellular space.
        Nature. 1980; 283: 249
        • Lewis R.E.
        • Johnson W.W.
        • Cruse J.M.
        Pitfalls and caveats in the methodology for immun-operoxidase staining in surgical pathology diagnosis.
        Surv Synth Path Res. 1983; 1: 134
        • Linder J.
        • Ye Y.
        • Harrington D.S.
        • et al.
        Monoclonal antibodies marking T lymphocytes in paraffin embedded tissue.
        Am J Pathol. 1987; 127: 1
        • Linder J.
        • Ye Y.
        • Armitage J.O.
        • et al.
        Monoclonal antibodies marking B-cell non-Hodgkin’s lymphoma in paraffin-embedded tissue.
        Mod Pathol. 1988; 1: 29
        • Listrom M.B.
        • Dalton L.W.
        Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2.
        Am J Clin Pathol. 1987; 88: 297
        • Michels S.
        • Swanson P.E.
        • Frizzera G.
        • et al.
        Immunostaining for leukocyte common antigen using an amplified avidin-biotin-peroxidase complex method and paraffin sections. A study of 735 hematopoietic and nonhematopoietic human neoplasms.
        Arch Pathol Lab Med. 1987; 111: 1035
        • Michie S.A.
        • Spagnolo D.V.
        • Dunn K.A.
        • et al.
        A panel approach to the evaluation of the sensitivity and specificity of antibodies for the diagnosis of routinely processed histologically undifferentiated human neoplasms.
        Am J Clin Pathol. 1987; 88: 457
        • Miettinen M.
        Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma.
        Arch Pathol Lab Med. 1988; 112: 637
        • Nadji M.
        • Tabei S.Z.
        • Castro A.
        • et al.
        Prostatic-specific antigen: An immunohistologic marker for prostatic neoplasms.
        Cancer. 1981; 48: 1229
        • Nagle R.B.
        • McDaniel K.M.
        • Clark V.A.
        • et al.
        The use of antikeratin antibodies in the diagnosis of human neoplasms.
        Am J Clin Pathol. 1983; 79: 458
        • Nakajima T.
        • Watanabe S.
        • Sato Y.
        • et al.
        An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues.
        Am J Surg Pathol. 1982; 6: 715
        • Norton A.J.
        • Isaacson P.G.
        Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
        Am J Pathol. 1987; 128: 225
        • Norton A.J.
        • Ramsay A.D.
        • Smith S.H.
        • et al.
        Monoclonal antibody (UCHL1) that recognizes normal and neoplastic T cells in routinely fixed tissues.
        J Clin Pathol. 1986; 39: 399
        • Otis C.N.
        • Carter D.
        • Cole S.
        • et al.
        Immunohistochemical evaluation of pleural mesothe lioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
        Am J Surg Pathol. 1987; 11: 445
        • Perentes E.
        • Rubinstein L.J.
        Recent applications of immunoperoxidase histochemistry in human neuro-oncology. An update.
        Arch Pathol Lab Med. 1987; 111: 796
        • Pinkus G.S.
        • Kurtin P.J.
        Epithelial membrane antigen—A diagnostic discriminant in surgical pathology: Immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.
        Hum Pathol. 1985; 16: 929
        • Poppema S.
        • Hollema H.
        • Visser L.
        • et al.
        Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.
        Am J Pathol. 1987; 127: 418
        • Said J.W.
        • Vimadalal S.
        • Nash G.
        • et al.
        Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
        Hum Pathol. 1985; 16: 236
        • Shah K.D.
        • Tabibzadeh S.S.
        • Gerber M.A.
        Comparison of cytokeratin expression in primary and metastatic carcinomas. Diagnostic application in surgical pathology.
        Am J Clin Pathol. 1987; 87: 708
        • Spagnolo D.V.
        • Michie S.A.
        • Crabtree G.S.
        • et al.
        Monoclonal anti-keratin (AE1) reactivity in routinely processed tissue from 166 human neoplasms.
        Am J Clin Pathol. 1985; 84: 697
        • Stein B.S.
        • Vangore S.
        • Peterson R.O.
        • et al.
        Immunoperoxidase localization of prostate-specific antigen.
        Am J Surg Pathol. 1982; 6: 553
        • Swanson P.E.
        Monoclonal antibodies to human milk fat globule proteins.
        in: Wick M.R. Siegal G.P. Monoclonal Antibodies in Diagnostic Immunohistochemistry. Marcel Dekker, New York1988: 227-283
        • Szpak C.A.
        • Johnston W.W.
        • Roggli V.
        • et al.
        The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
        Am J Pathol. 1986; 122: 252
        • Thomas P.
        • Battifora H.
        • Manderino G.L.
        • et al.
        A monoclonal antibody against neuron-specific enolase. Immunohistochemical comparison with a polyclonal antiserum.
        Am J Clin Pathol. 1987; 88: 146
        • Thomas P.
        • Battifora H.
        Keratins versus epithelial membrane antigen in tumor diagnosis: An immunohistochemical comparison of five monoclonal antibodies.
        Hum Pathol. 1987; 18: 728
        • Tsukada T.
        • McNutt M.A.
        • Ross R.
        • et al.
        HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues.
        Am J Pathol. 1987; 127: 389
        • Tsukada T.
        • Tippens D.
        • Gordon D.
        • et al.
        HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization.
        Am J Pathol. 1987; 126: 51
        • Warnke R.A.
        • Gatter K.C.
        • Falini B.
        • et al.
        Diagnosis of human lymphoma with monoclonal antileukocyte antibodies.
        N Engl J Med. 1983; 309: 1275
        • Warnock M.L.
        • Stoloff A.
        • Thor A.
        Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-schiff, monoclonal antibodies B72.3, and Leu Ml.
        Am J Pathol. 1988; 133: 30
        • Weiss S.W.
        • Bratthauer G.L.
        • Morris P.A.
        Postirradiation malignant fibrous histiocytoma expressing cytokeratin: Implications for the immunodiagnosis of sarcomas.
        Am J Surg Pathol. 1988; 12: 554
        • Wick M.R.
        Antibodies to desmin in diagnostic pathology.
        in: Wick M.R. Siegal G.P. Monoclonal Antibodies in Diagnostic Immunohistochemistry. Marcel Dekker, New York1988: 93-114

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30582-1

      Copyright

      © 1990 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX